RE:RE:RE:RE:RE:RE:Just Steps Away"just to let you know that even the biggest weed companies are 50% down." If you think you are a 'weed' company, then you need to realize that that bubble has burst! The hay days are over! Reality has set in.
"If you think you are a 'biotech' company, then you need to realize that your so called projects are NOT near completion and no one is left to back the much needed R&D funding! The ONLY substantial, outside funding that came into PREV....was from the Bridgemark Group, if you can believe that. That speaks volumes Stock, but not in a positive light.
Let me remind you that the news " preveceutical grants 51% asterion options to buy 51% of the sol gel IP" came out on august 6. The effective date was in july + the 2nd payment was on july 23rd. that means we will see the cash in the 3rd quarter ( JULY AUGUST SEPTEMBER)" Remind me? You are too funny Stock. :)
Yes the financial quarterly report covers July to September, but where you lack experience is.....the MD&A [as apposed to the Financials] always speaks from the "Effective Date". And in this case it is August 22, 2019. The very last line Stock....do check it out. But even that does not take away from the Management's MD&A statement of.....
Note:
(1) As of the date of this MD&A, Asterion has paid $20,000 to the Company for the July 22, 2019 Option payment and has not yet made payment to the Company for the August 22, 2019 Option payment. The Company has waived its right to deliver a termination notice to Asterion in respect of the termination of the Option Agreement as a result of such late payments until September 15, 2019.
I DID NOT write this Stock.....your Management did [last page of the MD&A]! They had to disclose, in the MD&A, as per Regulatory Rules, that they DID NOT receive the $650,000 payments due from Asterion by that 'effective'....but only $20k.
You are a stubborn man Stock, so I will remind you [as you say].......
PREV management disclosed in the MD&A, in black and white, that they did NOT receive the $325,000 July and Aug payments from Asterion for the acquistion of 51% Sol-Gel. They are now in arrears [default] Stock.
And to make matters worse, management is to decide by TODAY [Sept 15th] if they will deliver a 'termination notice' to Asterion, for their neglect to adhere to the terms of their agreement with PREV!
Is this that great partner you were mentioning earlier Stock? Van Deventer has been playing games with this stock for a long time now....even before getting into bed with the Bridgemark Group. I noticed it, others noticed it, but for some strange reason....you still cannot see it.
Stock514canada wrote: kk lets continue argumenting :)
1. I show you a visual of PREV trading at a 3 year low.....and you call it 'summer lows'? Wow!
The whole sector is trading very low since since we're in a bear market. IPO of prev was at 7c which is 50% down in the past 3 years which is very good considering we didnt make any money until now. Now its the best time to invest since all the programs are coming to an end .. ( revenues will come soon) .. just to let you know that even the biggest weed companies are 50% down.
2. I show you that Asterion is NOT making their monthly Sol-Gel acquisition payments to PREV.....and you say Asterion is going to commercialize Sol-Gel? Wow!
The second quarter ( APRIL MAY JUNE) was released a few weeks ago. Let me remind you that the news " preveceutical grants 51% asterion options to buy 51% of the sol gel IP" came out on august 6. The effective date was in july + the 2nd payment was on july 23rd. that means we will see the cash in the 3rd quarter ( JULY AUGUST SEPTEMBER)
https://www.preveceutical.com/_resources/news/nr_2019-08-06.pdf